Chemours Company Overview
Chemours Company Target Price
Analysts' 12-month price predictions for CC.
Share Price
$27.69
Average Target Price
$26.00
6.1% downside
6.1% downside4 analysts in the last 4 months
High: $34 | Low: $18
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-04-09 | BMO CapitalJohn McNulty | $34 |  22.8% upside |  |
| 2024-04-01 | UBSJoshua Spector | $28 | 1.1% upside | |
| 2024-04-01 | CFRAEmily Nassedd Mitsch | $18 | 35% downside | |
| 2024-03-13 | D.A. DavidsonLinda Bolton Weiser | $24 | 13.3% downside | |
| 2023-12-01 | RBC CapitalArun Viswanathan | $40 | 44.5% upside | |
| 2023-10-30 | Morgan StanleyVincent Andrews | $33 | 19.2% upside | |
| 2023-01-10 | RBC CapitalArun Viswanathan | $33 | 19.2% upside | |
| 2022-05-04 | RBC Capital | $48 | 73.3% upside | |
| 2021-05-20 | Bank of America SecuritiesMatthew DeYoe | $42 | 51.7% upside | |
| 2021-05-10 | Morgan StanleyVincent Andrews | $35 | 26.4% upside | |
| 2021-05-06 | Argus ResearchDavid Coleman | $40 | 44.5% upside | |